Telomerase inhibition and telomere erosion: A two-pronged strategy in cancer therapy

Trends in Pharmacological Sciences

Volumn 24, Issue 7, 2003, Pages 328-331

  Odago, Fred O ^a   Gerson, Stanton L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ANTIRETROVIRUS AGENT; ANTISENSE OLIGONUCLEOTIDE; CATECHIN; CURCUMIN; GENISTEIN; GRN 163; OLTIPRAZ; PACLITAXEL; RNA DERIVATIVE; TELOMERASE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG; ZIDOVUDINE;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CHEMOPROPHYLAXIS; DIETARY INTAKE; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE SILENCING; NONHUMAN; PHARYNX CANCER; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; TELOMERE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; NEOPLASM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; GENE EXPRESSION; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 0043235847     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00165-2     Document Type: Short Survey

References (13)

1. Hanahan D., et al. The hallmarks of cancer. Cell. 100:1997;57-70.
2. Corey D.R., et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14276-14281.
3. Counter C.M., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 5:1992;1921-1929.
4. Meyerson M., et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 90:1997;785-795.
5. Glover K.Y., Papadimitrakopoulou V.A. Chemoprevention of head and neck cancer. Curr. Oncol. Reports. 5:2003;152-157.
6. Kensler T.W., et al. Strategies for chemoprevention of liver cancer. Eur. J. Cancer Prev. (Suppl. 2):2002;S58-S64.
7. Gescher A.J., et al. Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol. 2:2001;371-379.
8. Strahl C., Blackburn E.H. The effects of nucleoside analogs on telomerase and telomeres in tetrahymena. Nucleic Acids Res. 22:1994;893-900.
9. Mo Y., et al. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res. 63:2003;579-585.
10. Corey D.R. Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene. 21:2002;631-637.
11. Shammas M.A., et al. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells. Oncogene. 18:1999;6191-6200.
12. Haider S.M., et al. Structure of a G-quadraplex-ligand complex. Cancer Res. 326:2003;117-125.
13. Bryan T.M., et al. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3:1997;1271-1274.